Numinus Wellness Inc.

Numinus Wellness Inc.

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial  VANCOUVER, BC, May 11, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, and Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (... Read More...

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab

Clinical trial will evaluate safety and psychoactive properties of natural Psilocybin product extracted and formulated at 7,000-square-foot laboratory in British Columbia, Canada VANCOUVER, BC, April 26, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-b... Read More...

Full-time classes resuming for secondary III, IV and V students in red zones: “A hasty and ill-advised decision given the spreading variants”

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Jan. 14, 2021 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Swiss Re Corporate Solutions’ first North American collaboration with Canadian insurer, Economical Insurance, to provide access to its International Programme Administration (IPA) platform and network services

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Jan. 21, 2021 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

46th annual conference of the Institut des troubles d’apprentissage – Learning disabilities on the rise: dealing with the new teaching reality

VANCOUVER, BC, Feb. 18, 2021 - Trading resumes in:Company: Sona Nanotech Inc.CSE Symbol: SONAAll Issues: NonResumption (ET): 2:48 PMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the nationa... Read More...

Tergus Lauded by Frost & Sullivan for Its Full-spectrum CRO Services for Therapeutics in Dermatology

SANTA CLARA, Calif., March 8, 2021 -- Based on its recent analysis of the North American contract research organization (CRO) market in dermatology, Frost & Sullivan recognizes Tergus Pharma (Tergus) with the 2020 North America Customer Value Leadership Award. It has continually built on technical, professional, and structural capabil... Read More...

Regulatory approvals place Numinus lab at the forefront of global psychedelics research

Numinus Bioscience adds Ketamine and LSD to licence to produce, assemble and sell a wide variety of psychedelic compounds VANCOUVER, BC, March 4, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a global leader in supporting and expanding the safe, accessible and evidence-based use of psychedelic-assisted psychotherapies (PAP), has ... Read More...

LogiNext, a global logistics tech company, partners with AmRest, one of the largest franchise operators of KFC, Pizza Hut, Burger King and Starbucks on last mile deliveries

Proceeds add to recently executed warrants and options of $8.9 million /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Dec. 29, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing... Read More...

Voyager Digital Announces Year to Date Growth Metrics

VANCOUVER, BC, Dec. 29, 2020 - The following issues have been halted by IIROC:Company: Numinus Wellness Inc.TSX-Venture Symbol: NUMIAll Issues: YesReason: At the Request of the Company Pending NewsHalt Time (ET): 8:07 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.... Read More...

Statement by the Prime Minister on the fourth anniversary of the fatal shooting at the Centre culturel islamique de Québec

OTTAWA, ON, Jan. 29, 2021 - The Prime Minister, Justin Trudeau, today issued the following statement to mark the fourth anniversary of the fatal shooting at the Centre culturel islamique de Québec:"Four years ago tonight, a terrorist attack at the Centre culturel islamique de Québec in Ste-Foy claimed the lives of six people and seriously... Read More...

Force One Capital is Retained to Provide Corporate Finance & Advisory Support to LocateMotion Inc.

TORONTO, Jan. 21, 2021 - Force One Capital Inc. ("Force One") is excited to announce it entered a strategic agreement with LocateMotion Inc. to provide capital markets and corporate finance advisory services in support of LocateMotion's upcoming financial offering.LocateMotion is the developer of Sensights.ai, an easy to use platform that... Read More...

Breeding tomorrow’s trees

The agreement will focus on developing safe, effective, all-natural products for the emerging psychedelic industry VANCOUVER, BC, Jan. 6, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedel... Read More...

Numinus Announces Grant of Stock Options

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Jan. 14, 2021 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer

Acquisition of industry-leading instrument by Thermo Fisher Scientific will significantly advance psychedelic research and accelerate third-party standardized testing capabilities VANCOUVER, BC, Jan. 13, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing an... Read More...

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

The agreement will focus on developing safe, effective, all-natural products for the emerging psychedelic industry  VANCOUVER, BC, Jan. 6, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychede... Read More...

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Proceeds add to recently executed warrants and options of $8.9 million /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Dec. 29, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming Français

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme

 First-of-its-kind policy amendment will allow legal access to evidence-based treatments to those in need before formal drug approval  VANCOUVER, BC, Dec. 11, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, access... Read More...

Numinus Wellness Inc. Announces an Increase to the Previously Announced Bought Deal Public Offering

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./VANCOUVER, BC, Dec. 7, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and suppo... Read More...

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

Monthly recurring revenue grows by more than 60% year over year. /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./OTTAWA, ON, Nov. 17, 2020 - Martello Technologies Group Inc., ("Martello") (TSXV: M... Read More...

Ontario Lottery and Gaming Corporation – MidDay lottery winning numbers – Nov. 18, 2020

Numinus Bioscience's developments include harvesting its first flush of Psilocybe mushrooms at its Health Canada licensed facility.VANCOUVER, BC, Oct. 22, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use ... Read More...

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders

Open-label clinical trial will evaluate and refine best practices for the delivery of psilocybin-assisted psychotherapy for participants with tobacco, stimulant, alcohol, and/or opioid disorders VANCOUVER, BC, Nov. 18, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of solutions centred on the resear... Read More...

Media advisory – Minister Ng to speak virtually to young entrepreneurs during Small Business Week

OTTAWA, ON, Oct. 21, 2020 - The Honourable Mary Ng, Minister of Small Business, Export Promotion and International Trade, will join young entrepreneurs at the "Trailblazers: Mental Health and Entrepreneurship" online event hosted by Futurpreneur Canada, in partnership with BDC. The Minister will deliver opening remarks prior to panellists... Read More...

Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory

Numinus progresses on its ecosystem approach to the ultimate delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies VANCOUVER, BC, Sept. 24, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, ac... Read More...

Numinus Announces Listing of Warrants

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Sept. 18, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Numinus Announces Filing of Final Short Form Prospectus for Offering of up to $4,000,000

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/VANCOUVER, BC, Sept. 3, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted ther... Read More...